Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Metformin and ageing: improving ageing outcomes beyond glycaemic control.

Valencia WM, Palacio A, Tamariz L, Florez H.

Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4349-5. [Epub ahead of print] Review.

PMID:
28770328
2.

Musculoskeletal Involvement in Hereditary Hemochromatosis.

Castellanos-Moreira R, Rodríguez-García SC, Florez H, Inciarte-Mundo J, Sanmarti R.

J Clin Rheumatol. 2017 Aug;23(5):291. doi: 10.1097/RHU.0000000000000544. No abstract available.

PMID:
28700532
3.

Hyperglycemia and dyslipidemia of Isabela, Galápagos, Ecuador: A pilot study of cardiovascular risk factors in an Isolated Island community.

Alexander A, Florez H, Ladera N.

Diabetes Res Clin Pract. 2017 Aug;130:108-112. doi: 10.1016/j.diabres.2017.05.015. Epub 2017 May 26.

PMID:
28601002
4.

Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.

Luchsinger JA, Ma Y, Christophi CA, Florez H, Golden SH, Hazuda H, Crandall J, Venditti E, Watson K, Jeffries S, Manly JJ, Pi-Sunyer FX; Diabetes Prevention Program Research Group.

Diabetes Care. 2017 Jul;40(7):958-965. doi: 10.2337/dc16-2376. Epub 2017 May 12.

PMID:
28500216
5.

How to prevent the microvascular complications of type 2 diabetes beyond glucose control.

Valencia WM, Florez H.

BMJ. 2017 Jan 17;356:i6505. doi: 10.1136/bmj.i6505. Review.

6.

Use of an online personal health record's Track Health function to promote positive lifestyle behaviors in Veterans with prediabetes.

Sharit J, Idrees T, Andrade AD, Anam R, Karanam C, Valencia W, Florez H, Ruiz JG.

J Health Psychol. 2016 Dec 1:1359105316681065. doi: 10.1177/1359105316681065. [Epub ahead of print]

PMID:
27920356
7.

Activity and Sedentary Time 10 Years After a Successful Lifestyle Intervention: The Diabetes Prevention Program.

Rockette-Wagner B, Storti KL, Dabelea D, Edelstein S, Florez H, Franks PW, Montez MG, Pomeroy J, Kriska AM; Diabetes Prevention Program Research Group.

Am J Prev Med. 2017 Mar;52(3):292-299. doi: 10.1016/j.amepre.2016.10.007. Epub 2016 Nov 22.

PMID:
27887769
8.

Transcultural Endocrinology: Adapting Type-2 Diabetes Guidelines on a Global Scale.

Nieto-Martínez R, González-Rivas JP, Florez H, Mechanick JI.

Endocrinol Metab Clin North Am. 2016 Dec;45(4):967-1009. doi: 10.1016/j.ecl.2016.06.002. Epub 2016 Oct 4. Review.

PMID:
27823615
9.

Fibrous dysplasia. Clinical review and therapeutic management.

Florez H, Peris P, Guañabens N.

Med Clin (Barc). 2016 Dec 16;147(12):547-553. doi: 10.1016/j.medcli.2016.07.030. Epub 2016 Oct 17. Review. English, Spanish.

PMID:
27765282
10.

Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial.

Zimering MB, Knight J, Ge L, Bahn G; VADT Investigators.

Front Endocrinol (Lausanne). 2016 Sep 8;7:123. doi: 10.3389/fendo.2016.00123. eCollection 2016.

11.

Biomedical Mutation Analysis (BMA): A software tool for analyzing mutations associated with antiviral resistance.

Salvatierra K, Florez H.

Version 2. F1000Res. 2016 Jun 3 [revised 2016 Aug 1];5:1141. doi: 10.12688/f1000research.8740.2. eCollection 2016.

12.

Lack of scintigraphic response of fibrous dysplasia to bisphosphonate treatment.

Florez H, Peris P, Vidal-Sicart S, Monegal A, Guañabens N.

Rheumatology (Oxford). 2016 Oct;55(10):1735. doi: 10.1093/rheumatology/kew284. Epub 2016 Jul 13. No abstract available.

PMID:
27411478
13.

A catalog of automated analysis methods for enterprise models.

Florez H, Sánchez M, Villalobos J.

Springerplus. 2016 Apr 2;5:406. doi: 10.1186/s40064-016-2032-9. eCollection 2016.

14.

Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association.

Munshi MN, Florez H, Huang ES, Kalyani RR, Mupanomunda M, Pandya N, Swift CS, Taveira TH, Haas LB.

Diabetes Care. 2016 Feb;39(2):308-18. doi: 10.2337/dc15-2512. Review.

15.

Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Vidot DC, Prado G, Hlaing WM, Florez HJ, Arheart KL, Messiah SE.

Am J Med. 2016 Feb;129(2):173-9. doi: 10.1016/j.amjmed.2015.10.019. Epub 2015 Nov 5.

17.

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV; VADT Investigators.

N Engl J Med. 2015 Jun 4;372(23):2197-206. doi: 10.1056/NEJMoa1414266. Erratum in: N Engl J Med. 2015 Jul 9;373(2):198.

18.

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.

Florez H, Reaven PD, Bahn G, Moritz T, Warren S, Marks J, Reda D, Duckworth W, Abraira C, Hayward R, Emanuele N; VADT Research Group.

Diabetes Obes Metab. 2015 Oct;17(10):949-55. doi: 10.1111/dom.12487. Epub 2015 Jun 17.

19.

The impact of lifestyle intervention on sedentary time in individuals at high risk of diabetes.

Rockette-Wagner B, Edelstein S, Venditti EM, Reddy D, Bray GA, Carrion-Petersen ML, Dabelea D, Delahanty LM, Florez H, Franks PW, Montez MG, Rubin R, Kriska AM; Diabetes Prevention Program Research Group.

Diabetologia. 2015 Jun;58(6):1198-202. doi: 10.1007/s00125-015-3565-0. Epub 2015 Apr 8.

20.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group.

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

Supplemental Content

Loading ...
Support Center